|
COPS2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.799980E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.462599999977E-06 |
| Normal-vs-Stage2 |
5.684100E-02 |
| Normal-vs-Stage3 |
1.159980E-01 |
| Normal-vs-Stage4 |
5.257000E-01 |
| Stage1-vs-Stage2 |
9.443000E-01 |
| Stage1-vs-Stage3 |
3.380300E-02 |
| Stage1-vs-Stage4 |
1.393990E-02 |
| Stage2-vs-Stage3 |
2.859200E-01 |
| Stage2-vs-Stage4 |
1.608760E-01 |
| Stage3-vs-Stage4 |
5.290400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76070999999833E-05 |
| Normal-vs-AfricanAmerican |
1.676450E-01 |
| Normal-vs-Asian |
7.953200E-01 |
| Caucasian-vs-AfricanAmerican |
4.41880000000561E-05 |
| Caucasian-vs-Asian |
3.049400E-01 |
| AfricanAmerican-vs-Asian |
6.905600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.016600E-04 |
| Normal-vs-Female |
8.319900E-03 |
| Male-vs-Female |
6.246600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.732000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.180480E-03 |
| Normal-vs-Age(61-80Yrs) |
8.766800E-04 |
| Normal-vs-Age(81-100Yrs) |
8.708200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.768400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.155400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.602800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.909800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.285750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.168200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.723500E-02 |
| Normal-vs-Grade 2 |
9.44369999977823E-08 |
| Normal-vs-Grade 3 |
6.066300E-02 |
| Normal-vs-Grade 4 |
3.271400E-01 |
| Grade 1-vs-Grade 2 |
9.361000E-01 |
| Grade 1-vs-Grade 3 |
1.290590E-01 |
| Grade 1-vs-Grade 4 |
2.362400E-02 |
| Grade 2-vs-Grade 3 |
1.619890E-04 |
| Grade 2-vs-Grade 4 |
1.47360000002372E-06 |
| Grade 3-vs-Grade 4 |
1.746340E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.99713595555795E-12 |
| Normal-vs-ccB subtype |
4.316200E-01 |
| ccA subtype-vs-ccB subtype |
8.01830002394865E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.379510E-03 |
| Normal-vs-N1 |
9.396800E-01 |
| N0-vs-N1 |
2.507000E-01 |
|
|
